Literature DB >> 25877928

Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs.

Darren J Lee1, Andrew W Taylor2.   

Abstract

The recovery of EAU, a mouse model of endogenous human autoimmune uveitis, is marked with the emergence of autoantigen-specific regulatory immunity in the spleen that protects the mice from recurrence of EAU. This regulatory immunity is mediated by a melanocortin-driven suppressor APC that presents autoantigen and uses adenosine to activate an antigen-specific CD4(+) Tregs through the A2Ar. These cells are highly effective in suppressing uveitis, and they appear to be inducible Tregs. In this study, we determined whether they are inducible or natural Tregs and identified the dependent mechanism for the function of these post-EAU Tregs. The post-EAU spleen CD25(+)CD4(+) T cells were sorted for NRP-1 expression and transferred to recipient mice immunized for EAU. The sorted NRP-1(-), but not the NRP-1(+), Tregs suppressed EAU. These NRP-1(-) Tregs coexpress PD-1 and PD-L1. Treatment of naive APCs with α-MSH promoted a regulatory APC that induced CD25(+) CD4(+) Tregs in a CD73-dependent manner. These Tregs were PD-L1(+) PD-1(+) NRP-1(-) FOXP3(+) HELIOS(-) and suppressed EAU when transferred to recipient mice. In contrast, PD-1(-) T cells did not suppress EAU, indicating that PD-1 is necessary for the suppressive activity of iTregs. Moreover, these Tregs did not suppress effector T cells when the PD/-1/PD-L1 pathway was blocked. These results demonstrate that post-EAU Tregs are inducible Tregs, which use a PD-1/PD-L1 mechanism to suppress disease. © Society for Leukocyte Biology.

Entities:  

Keywords:  adenosine; melanocortins; neuroimmunomodulation; ocular immunobiology; suppressor cells

Mesh:

Substances:

Year:  2015        PMID: 25877928      PMCID: PMC6608001          DOI: 10.1189/jlb.3A1014-466RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

1.  Tissue-specific production of MicroRNA-155 inhibits melanocortin 5 receptor-dependent suppressor macrophages to promote experimental autoimmune uveitis.

Authors:  Fauziyya Muhammad; Anna Trivett; Dawei Wang; Darren J Lee
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

2.  Comprehensive analysis of a mouse model of spontaneous uveoretinitis using single-cell RNA sequencing.

Authors:  Jacob S Heng; Sean F Hackett; Genevieve L Stein-O'Brien; Briana L Winer; John Williams; Loyal A Goff; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

3.  Exacerbation of autoimmune uveitis by obesity occurs through the melanocortin 5 receptor.

Authors:  Fauziyya Y Muhammad; Kayleigh Peters; Dawei Wang; Darren J Lee
Journal:  J Leukoc Biol       Date:  2019-07-09       Impact factor: 4.962

Review 4.  Resolution of uveitis.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

5.  Melanocortin receptor agonists suppress experimental autoimmune uveitis.

Authors:  Tat Fong Ng; Kaleb Dawit; Andrew W Taylor
Journal:  Exp Eye Res       Date:  2022-02-20       Impact factor: 3.770

6.  Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis.

Authors:  Hua Rong; Hongjie Shen; Yueli Xu; Hai Yang
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

7.  TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.

Authors:  Fauziyya Muhammad; Dawei Wang; Trisha McDonald; Marisa Walsh; Kayla Drenen; Alyssa Montieth; C Stephen Foster; Darren J Lee
Journal:  J Autoimmun       Date:  2020-03-20       Impact factor: 7.094

8.  MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response.

Authors:  Darren J Lee; Janine Preble; Stacey Lee; C Stephen Foster; Andrew W Taylor
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

Review 9.  Quantitative Assessment of Experimental Ocular Inflammatory Disease.

Authors:  Lydia J Bradley; Amy Ward; Madeleine C Y Hsue; Jian Liu; David A Copland; Andrew D Dick; Lindsay B Nicholson
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 10.  Intraocular Implants for the Treatment of Autoimmune Uveitis.

Authors:  Darren J Lee
Journal:  J Funct Biomater       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.